HomeCompareCFMS vs PLD

CFMS vs PLD: Dividend Comparison 2026

CFMS yields 88.11% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $4.14M in total portfolio value· pulled ahead in Year 10
10 years
CFMS
CFMS
● Live price
88.11%
Share price
$2.27
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.37M
Annual income
$731,873.50
Full CFMS calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — CFMS vs PLD

📍 PLD pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCFMSPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CFMS + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CFMS pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CFMS
Annual income on $10K today (after 15% tax)
$7,488.99/yr
After 10yr DRIP, annual income (after tax)
$622,092.48/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, PLD beats the other by $3,845,878.28/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CFMS + PLD for your $10,000?

CFMS: 50%PLD: 50%
100% PLD50/50100% CFMS
Portfolio after 10yr
$4.44M
Annual income
$2,994,154.84/yr
Blended yield
67.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

CFMS
Analyst Ratings
2
Buy
3
Hold
1
Sell
Consensus: Hold
Altman Z
-12.5
Piotroski
2/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CFMS buys
0
PLD buys
0
No recent congressional trades found for CFMS or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCFMSPLD
Forward yield88.11%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$2.37M$6.50M
Annual income after 10y$731,873.50$5,256,436.18
Total dividends collected$2.08M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy

Year-by-year: CFMS vs PLD ($10,000, DRIP)

YearCFMS PortfolioCFMS Income/yrPLD PortfolioPLD Income/yrGap
1$19,511$8,810.57$11,255$555.24+$8.3KCFMS
2$36,942$16,065.36$13,062$1,018.59+$23.9KCFMS
3$67,956$28,428.44$15,903$1,926.67+$52.1KCFMS
4$121,587$48,874.33$20,839$3,823.32+$100.7KCFMS
5$211,824$81,725.42$30,464$8,166.08+$181.4KCFMS
6$359,715$133,063.84$52,054$19,457.30+$307.7KCFMS
7$596,079$211,183.71$109,886$54,188.93+$486.2KCFMS
8$964,860$327,055.60$304,030$186,451.18+$660.8KCFMS
9$1,527,165$494,764.27$1,166,125$840,813.32+$361.0KCFMS
10← crossover$2,365,940$731,873.50$6,504,190$5,256,436.18$4.14MPLD

CFMS vs PLD: Complete Analysis 2026

CFMSStock

Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruciate retaining total knee replacement product; iTotal PS, a posterior stabilized knee replacement product, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also provides Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.

Full CFMS Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this CFMS vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CFMS vs SCHDCFMS vs JEPICFMS vs OCFMS vs KOCFMS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.